ITMCTR2026001714进行中(未招募)Unknown
Randomized Controlled, Double-Blind, Double-Simulated Study on Qianlie Tongluo Decoction in the Treatment of Type III Chronic Nonbacterial Prostatitis with Damp-Heat Stasis Syndrome
Dongzhimen Hospital, Beijing University of Chinese Medicine0 个研究点开始时间: 2026年7月13日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 进行中(未招募)
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 50(—)
- 性别
- Male
入选标准
- •(1) Male patients meeting the Western medicine diagnostic criteria for type III prostatitis;
- •(2) NIH-CPSI score > 10 points;
- •(3) Patients conforming to the syndrome differentiation standard of damp-heat stagnation and blood stasis syndrome;
- •(4) Patients with relevant symptoms consistent with diagnostic criteria lasting for more than 3 months;
- •(5) Aged from 18 to 50 years old (inclusive);
- •(6) No antibiotics or treatments for chronic prostatitis administered within 2 weeks before enrollment;
- •(7) No other medications taken by patients within two weeks prior to enrollment;
- •(8) Patients fully informed of the trial conditions and voluntarily signed the informed consent form.
排除标准
- •(1) Patients complicated with prostatic tumors, neurogenic bladder dysfunction, urethral malformation or stricture, and severe neurosis.
- •(2) Patients with urinary tract infection or urethritis.
- •(3) For patients presenting mainly with local pain, other diseases involving lower abdomen, perineum, lumbosacral region and other parts shall be excluded, such as ureteral or vesical calculi, inguinal hernia, pubic osteitis, varicocele, epididymitis, colorectal diseases, lumbodorsal fasciitis, etc.
- •(4) Patients complicated with severe primary diseases of cardiovascular and cerebrovascular systems, liver, kidney and hematopoietic system.
- •(5) Subjects participating in other clinical drug trials concurrently or taking drugs with similar therapeutic effects to the trial medication.
- •(6) Patients who use Chinese and Western medicines, health products, or herbal decoctions containing prescribed medicinal slices with therapeutic effects on this disease during the trial period.
- •(7) Patients with fertility requirements.
研究者
相似试验
进行中(未招募)
3 期
A study to evaluate the efficacy and safety of QVM149 (indacaterol
acetate / glycopyrronium bromide / mometasone furoate) versus salmeterol
xinafoate/fluticasone propionate in children from 12 years to less than 18 years of
age with asthma.RespiratoryPACTR202607586774191Novartis Pharma AG32
尚未招募
不适用
An Exploratory, Randomized, Double-Blind, Parallel-Group Controlled Trial to Evaluate the Safety of L-Aspartate Sodium and L-Cystine Intake in Healthy AdultsHealthy adultsjRCT1050260004200
招募中
不适用
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma (PEAK-1)Advanced or metastatic clear cell renal cell carcinoma (ccRCC)jRCT205126000965
招募中
不适用
A phase IIb, Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group, Dose-Ranging Study of M610101 in Patients with Nonsegmental VitiligoNon-segmental vitiligojRCT2031260035120
尚未招募
不适用
A study to evaluate the efficacy and safety of ELGN-2112 on intestinal malabsorption in preterm infants as compared to placebo. (FIT-PIV)Intestinal Malabsorption in Preterm InfantsjRCT203126028220
